Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Immuno-cosmeceuticals from chicken egg yolk can effectively repair and improve damaged hair.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Tofacitinib is a promising treatment for children with rheumatic diseases.

TLR4 is important in aging-related diseases and could be a new treatment target.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Coconut seed extract may effectively treat scabies in rabbits by killing mites and reducing inflammation.

Treatment improved PCOS symptoms and reduced BMI and certain immune factors.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Mammals might fail to regenerate not because they lack the right cells, but because of how cells respond to their surroundings, and changing this environment could enhance regeneration.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

Prolactin may be important for skin growth and immune function.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Modifying certain signals in the body can help wounds heal without scars and regrow hair.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.